Zoetis
ZTS
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Zoetis Inc. is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products, biodevices, genetic tests and precision livestock farming technology. The Company has a business, commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, swine, poultry, fish and sheep (collectively, livestock); and within product categories such as vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. The Company's segments include the United States and International. Within each of these operating segments, it offers a product portfolio for both livestock and companion animal customers.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Zacks Investment Research • 1 day ago • ZTS
Here's Why Zoetis (ZTS) is a Strong Value Stock
Seeking Alpha • 5 days ago • ZTS
Diamond Hill Mid Cap Fund Q4 2025 Portfolio Review
Business Wire • 5 days ago • ZTS
Zoetis to Acquire Animal Genomics Business from NeogenĀ®, Accelerating Precision Animal Health Innovation
Seeking Alpha • 5 days ago • ZTS
Top 15 High-Growth Dividend Stocks For March 2026
Zacks Investment Research • 8 days ago • ZTS
Buy 5 Stocks With High ROE as Markets Dance Whimsically to the AI Tune
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.